BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32784523)

  • 1. Aberrant CXCR4 Signaling at Crossroad of WHIM Syndrome and Waldenstrom's Macroglobulinemia.
    Milanesi S; Locati M; Borroni EM
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHIM Syndrome Caused by Waldenström's Macroglobulinemia-Associated Mutation CXCR4 (L329fs).
    Liu Q; Pan C; Lopez L; Gao J; Velez D; Anaya-O'Brien S; Ulrick J; Littel P; Corns JS; Ellenburg DT; Malech HL; Murphy PM; McDermott DH
    J Clin Immunol; 2016 May; 36(4):397-405. PubMed ID: 27059040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The negative charge of the 343 site is essential for maintaining physiological functions of CXCR4.
    Wang L; Xiong Q; Li P; Chen G; Tariq N; Wu C
    BMC Mol Cell Biol; 2021 Jan; 22(1):8. PubMed ID: 33485325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of the chemokine receptor CXCR4.
    Luo J; De Pascali F; Richmond GW; Khojah AM; Benovic JL
    J Biol Chem; 2022 Feb; 298(2):101551. PubMed ID: 34973340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The WHIM-like CXCR4(S338X) somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom's Macroglobulinemia.
    Cao Y; Hunter ZR; Liu X; Xu L; Yang G; Chen J; Patterson CJ; Tsakmaklis N; Kanan S; Rodig S; Castillo JJ; Treon SP
    Leukemia; 2015 Jan; 29(1):169-76. PubMed ID: 24912431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed survival signalling in Waldenström macroglobulinaemia cells.
    Cao Y; Hunter ZR; Liu X; Xu L; Yang G; Chen J; Tsakmaklis N; Kanan S; Castillo JJ; Treon SP
    Br J Haematol; 2015 Mar; 168(5):701-7. PubMed ID: 25371371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptors.
    Gómez-Moutón C; Fischer T; Peregil RM; Jiménez-Baranda S; Stossel TP; Nakamura F; Mañes S
    Blood; 2015 Feb; 125(7):1116-25. PubMed ID: 25355818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL12/CXCR4-axis dysfunctions: Markers of the rare immunodeficiency disorder WHIM syndrome.
    Bachelerie F
    Dis Markers; 2010; 29(3-4):189-98. PubMed ID: 21178277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis.
    Hunter ZR; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Manning RJ; Tripsas C; Patterson CJ; Sheehy P; Treon SP
    Blood; 2014 Mar; 123(11):1637-46. PubMed ID: 24366360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 in Waldenström's Macroglobulinema: chances and challenges.
    Kaiser LM; Hunter ZR; Treon SP; Buske C
    Leukemia; 2021 Feb; 35(2):333-345. PubMed ID: 33273682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4 signaling in health and disease.
    Pozzobon T; Goldoni G; Viola A; Molon B
    Immunol Lett; 2016 Sep; 177():6-15. PubMed ID: 27363619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM.
    Scala S; D'Alterio C; Milanesi S; Castagna A; Carriero R; Farina FM; Locati M; Borroni EM
    Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32260318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients.
    García-Cuesta EM; Rodríguez-Frade JM; Gardeta SR; D'Agostino G; Martínez P; Soler Palacios B; Cascio G; Wolf T; Mateos N; Ayala-Bueno R; Santiago CA; Lucas P; Llorente L; Allende LM; González-Granado LI; Martín-Cófreces N; Roda-Navarro P; Sallusto F; Sánchez-Madrid F; García-Parajo MF; Martínez-Muñoz L; Mellado M
    Proc Natl Acad Sci U S A; 2022 May; 119(21):e2119483119. PubMed ID: 35588454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4
    Zmajkovicova K; Pawar S; Maier-Munsa S; Maierhofer B; Wiest I; Skerlj R; Taveras AG; Badarau A
    Genes Immun; 2022 Sep; 23(6):196-204. PubMed ID: 36089616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
    Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
    Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Waldenström's macroglobulinemia and its individualized therapy options].
    Szemlaky Z; Mikala G
    Orv Hetil; 2017 Oct; 158(41):1604-1614. PubMed ID: 29025291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia.
    Xu L; Hunter ZR; Tsakmaklis N; Cao Y; Yang G; Chen J; Liu X; Kanan S; Castillo JJ; Tai YT; Zehnder JL; Brown JR; Carrasco RD; Advani R; Sabile JM; Argyropoulos K; Lia Palomba M; Morra E; Trojani A; Greco A; Tedeschi A; Varettoni M; Arcaini L; Munshi NM; Anderson KC; Treon SP
    Br J Haematol; 2016 Mar; 172(5):735-44. PubMed ID: 26659815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-level Cxcr4-haploinsufficient HSC engraftment is sufficient to correct leukopenia in WHIM syndrome mice.
    Gao JL; Owusu-Ansah A; Paun A; Beacht K; Yim E; Siwicki M; Yang A; Liu Q; McDermott DH; Murphy PM
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31687976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.
    Liu Q; Chen H; Ojode T; Gao X; Anaya-O'Brien S; Turner NA; Ulrick J; DeCastro R; Kelly C; Cardones AR; Gold SH; Hwang EI; Wechsler DS; Malech HL; Murphy PM; McDermott DH
    Blood; 2012 Jul; 120(1):181-9. PubMed ID: 22596258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome.
    Lagane B; Chow KY; Balabanian K; Levoye A; Harriague J; Planchenault T; Baleux F; Gunera-Saad N; Arenzana-Seisdedos F; Bachelerie F
    Blood; 2008 Jul; 112(1):34-44. PubMed ID: 18436740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.